Surender Kharbanda - 11 Jan 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
10%+ Owner
Signature
/s/ Surender Kharbanda
Issuer symbol
THAR
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
3
Filing time
11 Jan 2022, 20:53:52 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HILS Common stock 721,240 11 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HILS Options (right to purchase) 11 Jan 2022 Common stock 946 $7.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Registrant issued the Reporting Person the options on January 1, 2021. The options vested and became exercisable immediately upon grant.